Income Statement C&R Research Inc.

Stocks

A359090

KR7359090008

Biotechnology & Medical Research

End-of-day quote Korea S.E. 2026-08-24			5-day change	1st Jan Change
1,935.00 ^KRW	-0.87%		-3.97%	-57.00%

03-30	C&R Research Inc wins 11.5 billion won order	RE
11-05	C&R Research Inc. announces Annual dividend, payable on April 13, 2026	CI

94497c15.J9FKiurlNXTashrj3v9TvpxmubJSbjcGnzD4tZYF9xQ.f5ATvKmvdi6Ji12uiIo90NAxgPhhCFZE6lmZg9FDr3J2pxru34BzQoPLIg

Published financial data: C&R RESEARCH INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	43.17B	48.5B	55.1B	59.69B	64.98B
Total Revenues	43.17B	48.5B	55.1B	59.69B	64.98B
Gross Profit	43.17B	48.5B	55.1B	59.69B	64.98B
Selling General & Admin Expenses, Total	35.68B	41.92B	46.31B	53.32B	59.33B
Provision for Bad Debts	62.08M	-	-	20K	1.44B
Depreciation & Amortization - (IS)	681M	651M	591M	1.04B	792M
Amortization of Goodwill and Intangible Assets - (IS)	-	-	554M	149M	352M
Other Operating Expenses	997M	1.22B	1.42B	1.55B	1.68B
Other Operating Expenses, Total	37.42B	43.79B	48.87B	56.06B	63.6B
Operating Income	5.75B	4.71B	6.23B	3.63B	1.38B
Interest Expense, Total	-511M	-381M	-394M	-275M	-218M
Interest And Investment Income	5.22M	246M	331M	368M	247M
Net Interest Expenses	-506M	-135M	-63.22M	92.7M	29.11M
Income (Loss) On Equity Invest.	-397M	-407M	-439M	-1.93B	-494M
Currency Exchange Gains (Loss)	-55.56M	-12.56M	-17.65M	65.78M	68.13M
Other Non Operating Income (Expenses)	-7.52B	11.27M	7.51M	166M	8.71M
EBT, Excl. Unusual Items	-2.72B	4.16B	5.72B	2.03B	996M
Gain (Loss) On Sale Of Investments	-	-	-	1.89B	7.7M
Gain (Loss) On Sale Of Assets	-	-	-	-7.5M	-3.53M
Asset Writedown	-	-73.16M	70M	-229M	-
EBT, Incl. Unusual Items	-2.72B	4.09B	5.79B	3.68B	1B
Income Tax Expense	580M	164M	244M	323M	-20.67M
Earnings From Continuing Operations	-3.3B	3.93B	5.55B	3.36B	1.02B
Earnings Of Discontinued Operations	-	-	13.04M	-	-
Net Income to Company	-3.3B	3.93B	5.56B	3.36B	1.02B
Minority Interest	3.47M	1.15M	2.58M	480M	1.56B
Net Income - (IS)	-3.3B	3.93B	5.56B	3.84B	2.59B
Net Income to Common Incl Extra Items	-3.3B	3.93B	5.56B	3.84B	2.59B
Net Income to Common Excl. Extra Items	-3.3B	3.93B	5.55B	3.84B	2.59B
Per Share Items
Net EPS - Basic	-3.33K	366.14	509.42	342.35	226.79
Basic EPS - Continuing Operations	-3.33K	366.14	508.23	342.35	226.79
Basic Weighted Average Shares Outstanding	992K	10.73M	10.92M	11.21M	11.4M
Net EPS - Diluted	-3.33K	365	499.51	340	226.47
Diluted EPS - Continuing Operations	-3.33K	365	498.35	340	226.47
Diluted Weighted Average Shares Outstanding	992K	10.73M	11.26M	11.29M	11.42M
Normalized Basic EPS	-1.71K	242.68	327.67	155.79	191.84
Normalized Diluted EPS	-1.71K	242.68	317.76	154.74	191.57
Dividend Per Share	-	-	-	50	-
Payout Ratio	-	-	-	-	21.94
Supplemental Items
EBITDA	6.43B	5.36B	7.38B	4.82B	2.53B
EBITA	5.75B	4.71B	6.79B	4.17B	1.74B
EBIT	5.75B	4.71B	6.23B	3.63B	1.38B
EBITDAR	6.75B	5.7B	7.67B	5.12B	2.84B
Effective Tax Rate - (Ratio)	-21.29	4	4.21	8.77	-2.07
Normalized Net Income	-1.7B	2.6B	3.58B	1.75B	2.19B
Supplemental Operating Expense Items
Selling and Marketing Expenses	7.42B	8.18B	8.5B	11.83B	12.21B
General and Administrative Expenses	270M	294M	324M	340M	378M
Net Rental Expense, Total	311M	347M	293M	306M	315M
Imputed Operating Lease Interest Expense	-	96.2M	129M	113M	87.11M
Imputed Operating Lease Depreciation	-	251M	164M	193M	228M
Stock-Based Comp., SG&A Exp. (Total)	233M	225M	158M	57.87M	-
Total Stock-Based Compensation	233M	225M	158M	57.87M	-

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	19.45B	6.51B	7.26B	12.12B	8.85B
Short Term Investments	-	4.18B	4.64B	1B	-
Trading Asset Securities, Total	-	-	-	-	1.01B
Total Cash And Short Term Investments	19.45B	10.69B	11.9B	13.12B	9.86B
Accounts Receivable, Total	2.72B	2.66B	5.36B	9.52B	8.2B
Other Receivables	3.7M	78.28M	67.66M	336M	15.36M
Notes Receivable	600M	0	-	-	200M
Total Receivables	3.32B	2.74B	5.43B	9.86B	8.42B
Prepaid Expenses	111M	179M	210M	380M	277M
Other Current Assets, Total	12.89B	15.71B	18.98B	20.97B	22.11B
Total Current Assets	35.77B	29.32B	36.52B	44.33B	40.66B
Gross Property Plant And Equipment	35.71B	34.67B	34.84B	35.94B	36.23B
Accumulated Depreciation	-4.25B	-4.73B	-4.97B	-5.31B	-6.01B
Net Property Plant And Equipment	31.46B	29.94B	29.86B	30.63B	30.22B
Long-term Investments	3.4B	7.76B	8.45B	4.84B	8.04B
Goodwill	-	-	-	3.26B	3.26B
Other Intangibles, Total	549M	2.93B	2.47B	1.98B	1.76B
Deferred Tax Assets Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	84.88M	562M	548M	556M	750M
Total Assets	71.27B	70.51B	77.85B	85.6B	84.69B
Liabilities
Accounts Payable, Total	4.7B	3.32B	3.87B	3.93B	5.03B
Accrued Expenses, Total	28.66M	48.54M	422M	569M	284M
Short-term Borrowings	2B	-	-	705M	6.64B
Current Portion of Long-Term Debt	10.45B	6.45B	5B	4B	-
Current Portion of Leases	139M	197M	192M	331M	303M
Current Income Taxes Payable	-	-	-	-	184M
Other Current Liabilities	19.36B	20.8B	22.07B	25.84B	21.84B
Total Current Liabilities	36.68B	30.82B	31.56B	35.37B	34.29B
Long-Term Debt	1.5B	974M	1.06B	-	-
Long-Term Leases	97.85M	166M	246M	411M	239M
Pension & Other Post Retirement Benefits	-	-	29.39M	65.42M	-
Deferred Tax Liability Non Current	2.52B	2.5B	2.47B	2.32B	1.96B
Other Non Current Liabilities	10	100	-10	337M	328M
Total Liabilities	40.8B	34.45B	35.35B	38.51B	36.81B
Preferred Stock Redeemable	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	5.25B	5.43B	5.49B	5.67B	5.75B
Additional Paid In Capital	23.75B	25.44B	26.15B	27.88B	28.69B
Retained Earnings	-10.77B	-6.84B	-1.27B	2.56B	4.58B
Treasury Stock	-949K	-949K	-949K	-949K	-949K
Comprehensive Income and Other	12.25B	12.02B	11.87B	10.79B	10.4B
Total Common Equity	30.48B	36.06B	42.23B	46.91B	49.42B
Minority Interest	-13.28M	-	262M	189M	-1.54B
Total Equity	30.47B	36.06B	42.49B	47.09B	47.88B
Total Liabilities And Equity	71.27B	70.51B	77.85B	85.6B	84.69B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	10.5M	10.86M	10.97M	11.35M	11.49M
ECS Total Common Shares Outstanding	10.5M	10.86M	10.97M	11.35M	11.49M
Book Value / Share	2.9K	3.32K	3.85K	4.13K	4.3K
Tangible Book Value	29.94B	33.13B	39.76B	41.66B	44.4B
Tangible Book Value Per Share	2.85K	3.05K	3.62K	3.67K	3.86K
Total Debt	14.19B	7.79B	6.49B	5.45B	7.19B
Net Debt	-5.26B	-2.9B	-5.41B	-7.67B	-2.67B
Debt Equivalent Oper. Leases	2.49B	2.77B	2.34B	2.45B	2.52B
Minority Interest, Total (Incl. Fin. Div)	-13.28M	-	262M	189M	-1.54B
Equity Method Investments, Total	2.73B	6.63B	6.19B	3.39B	2.95B
Land - (BS)	26.45B	26.45B	26.45B	26.45B	26.45B
Buildings, Total	3.32B	3.32B	3.32B	3.32B	3.32B
Machinery, Total	2.59B	2.64B	2.79B	3B	3.04B
Accumulated Allowance for Doubtful Accounts (Supple)	18.59M	3.23M	28.9M	11.83M	1.13B

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-3.3B	3.93B	5.56B	3.84B	2.59B
Depreciation & Amortization - CF	684M	650M	591M	651M	792M
Amortization of Goodwill and Intangible Assets - (CF)	-	-	554M	538M	352M
Depreciation & Amortization, Total	684M	650M	1.14B	1.19B	1.14B
(Gain) Loss From Sale Of Asset	-	-	-	237M	3.53M
(Gain) Loss on Sale of Investments - (CF)	-	2.6M	-	-1.89B	-7.7M
Asset Writedown & Restructuring Costs	-	73.16M	-70M	-	-
(Income) Loss On Equity Investments - (CF)	397M	407M	438M	1.93B	494M
Stock-Based Compensation (CF)	233M	225M	158M	57.87M	-
Provision and Write-off of Bad Debts	-230M	-28.42M	24.48M	-22.43M	1.44B
Other Operating Activities, Total	7.58B	190M	205M	238M	-927M
Change In Accounts Receivable	-700M	85.55M	-2.72B	-3.58B	-2.79B
Change In Income Taxes	-285K	-13.41M	-9.84M	-22.47M	73.51M
Change In Deferred Taxes	-	-2.6M	-22.76M	84.89M	-
Change in Other Net Operating Assets	-2.41B	-3B	-1.2B	787M	-5.08B
Cash from Operations	2.25B	2.52B	3.51B	2.84B	-3.07B
Capital Expenditure	-1.25B	-872M	-193M	-655M	-171M
Sale of Property, Plant, and Equipment	-	983K	1.59M	-	1.74M
Cash Acquisitions	2.42B	-	-	-	-
Sale (Purchase) of Intangible assets	-33.68M	-386M	-25.87M	-154M	-125M
Investment in Marketable and Equity Securities, Total	12.88B	-8.98B	-1.61B	3.34B	-905M
Net (Increase) Decrease in Loans Originated / Sold - Investing	-600M	600M	-	-2B	-200M
Other Investing Activities, Total	73.9M	-496M	34.15M	1.15B	-198M
Cash from Investing	13.49B	-10.14B	-1.8B	1.68B	-1.6B
Short Term Debt Issued, Total	2B	-	-	1B	2B
Total Debt Issued	2B	-	-	1B	2B
Short Term Debt Repaid, Total	-3.97B	-3B	-	-25.46M	-60M
Long-Term Debt Repaid, Total	-217M	-3.17B	-1.7B	-1.32B	-436M
Total Debt Repaid	-4.19B	-6.17B	-1.7B	-1.34B	-496M
Issuance of Common Stock	1.27B	853M	481M	575M	622M
Common & Preferred Stock Dividends Paid	-	-	-	-	-567M
Common & Preferred Stock Dividends Paid	-	-	-	-	-567M
Other Financing Activities, Total	680	-3.52M	263M	510	-195M
Cash from Financing	-919M	-5.32B	-959M	231M	1.36B
Foreign Exchange Rate Adjustments	78.5K	-6.22M	-8.93M	107M	29.15M
Net Change in Cash	14.82B	-12.94B	747M	4.86B	-3.27B
Supplemental Items
Cash Interest Paid	304M	257M	289M	243M	193M
Cash Income Tax Paid (Refund)	57.01K	36.48M	4.04M	806K	91.51M
Levered Free Cash Flow	-	90.49M	936M	-81.5M	-1.01B
Unlevered Free Cash Flow	-	329M	1.18B	90.6M	-877M
Change In Net Working Capital	-	2.23B	3.8B	2.62B	2.59B
Net Debt Issued / Repaid	-2.19B	-6.17B	-1.7B	-343M	1.5B

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-	4.15	5.25	2.78	1.02
Return on Total Capital	-	6.65	8.39	4.47	1.61
Return On Equity %	-	11.81	14.12	7.5	2.15
Return on Common Equity	-	11.81	14.18	8.61	5.37
Margin Analysis
Gross Profit Margin %	100	100	100	100	100
SG&A Margin	82.65	86.44	84.04	89.34	91.31
EBITDA Margin %	14.91	11.05	13.39	8.07	3.89
EBITA Margin %	13.32	9.71	12.32	6.98	2.67
EBIT Margin %	13.32	9.71	11.31	6.08	2.13
Income From Continuing Operations Margin %	-7.65	8.1	10.07	5.63	1.57
Net Income Margin %	-7.65	8.1	10.09	6.43	3.98
Net Avail. For Common Margin %	-7.65	8.1	10.07	6.43	3.98
Normalized Net Income Margin	-3.94	5.37	6.49	2.93	3.37
Levered Free Cash Flow Margin	-	0.19	1.7	-0.14	-1.56
Unlevered Free Cash Flow Margin	-	0.68	2.14	0.15	-1.35
Asset Turnover
Asset Turnover	-	0.68	0.74	0.73	0.76
Fixed Assets Turnover	-	1.58	1.84	1.97	2.14
Receivables Turnover (Average Receivables)	-	18.03	13.74	8.02	7.33
Short Term Liquidity
Current Ratio	0.98	0.95	1.16	1.25	1.19
Quick Ratio	0.6	0.44	0.55	0.65	0.53
Operating Cash Flow to Current Liabilities	0.06	0.08	0.11	0.08	-0.09
Days Sales Outstanding (Average Receivables)	-	20.25	26.57	45.63	49.77
Long Term Solvency
Total Debt/Equity	46.57	21.6	15.28	11.57	15.01
Total Debt / Total Capital	31.77	17.76	13.26	10.37	13.05
LT Debt/Equity	5.26	3.16	3.06	0.87	0.5
Long-Term Debt / Total Capital	3.59	2.6	2.66	0.78	0.43
Total Liabilities / Total Assets	57.25	48.86	45.41	44.99	43.47
EBIT / Interest Expense	11.25	12.35	15.83	13.18	6.35
EBITDA / Interest Expense	12.59	14.06	18.74	17.5	11.59
(EBITDA - Capex) / Interest Expense	10.15	11.77	18.25	15.12	10.81
Total Debt / EBITDA	2.21	1.45	0.88	1.13	2.84
Net Debt / EBITDA	-0.82	-0.54	-0.73	-1.59	-1.06
Total Debt / (EBITDA - Capex)	2.74	1.74	0.9	1.31	3.05
Net Debt / (EBITDA - Capex)	-1.01	-0.65	-0.75	-1.84	-1.13
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	12.34	13.68	8.32	8.87
Gross Profit, 1 Yr. Growth %	-	12.34	13.68	8.32	8.87
EBITDA, 1 Yr. Growth %	-	-16.74	35.37	-34.67	-47.54
EBITA, 1 Yr. Growth %	-	-18.14	41.39	-38.58	-58.34
EBIT, 1 Yr. Growth %	-	-18.14	29.85	-41.75	-61.86
Earnings From Cont. Operations, 1 Yr. Growth %	-	-218.87	38	-39.45	-69.6
Net Income, 1 Yr. Growth %	-	-219.03	41.59	-30.99	-32.64
Normalized Net Income, 1 Yr. Growth %	-	-253.25	34.84	-51.18	25.21
Diluted EPS Before Extra, 1 Yr. Growth %	-	-110.96	33	-31.78	-33.39
Accounts Receivable, 1 Yr. Growth %	-	-1.96	101.16	77.72	-13.89
Net Property, Plant and Equip., 1 Yr. Growth %	-	-4.85	-0.25	2.58	-1.35
Total Assets, 1 Yr. Growth %	-	-1.07	10.41	9.96	-1.07
Tangible Book Value, 1 Yr. Growth %	-	10.67	20.03	4.77	6.59
Common Equity, 1 Yr. Growth %	-	18.28	17.13	11.07	5.36
Cash From Operations, 1 Yr. Growth %	-	12.16	39.21	-19.15	-210.29
Capital Expenditures, 1 Yr. Growth %	-	-30.1	-77.86	239.28	-73.97
Levered Free Cash Flow, 1 Yr. Growth %	-	-	532.6	-108.71	1.14K
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-	206.15	-92.33	-1.07K
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	25.98	-	12.98	10.97	8.6
Gross Profit, 2 Yr. CAGR %	25.98	-	12.98	10.97	8.6
EBITDA, 2 Yr. CAGR %	407.22	-	7.07	-5.96	-41.46
EBITA, 2 Yr. CAGR %	345.27	-	8.63	-6.81	-49.41
EBIT, 2 Yr. CAGR %	345.27	-	4.1	-13.03	-52.87
Earnings From Cont. Operations, 2 Yr. CAGR %	40.2	-	29.57	-8.59	-57.09
Net Income, 2 Yr. CAGR %	40.07	-	29.82	-1.15	-31.82
Normalized Net Income, 2 Yr. CAGR %	34.67	-	45.11	-18.86	-21.82
Diluted EPS Before Extra, 2 Yr. CAGR %	-22.94	-	-61.31	-4.74	-32.59
Accounts Receivable, 2 Yr. CAGR %	29.41	-	40.43	89.08	23.7
Net Property, Plant and Equip., 2 Yr. CAGR %	16.77	-	-2.57	1.16	0.6
Total Assets, 2 Yr. CAGR %	34.71	-	4.51	10.19	4.3
Tangible Book Value, 2 Yr. CAGR %	186.83	-	15.25	12.14	5.67
Common Equity, 2 Yr. CAGR %	214.71	-	17.7	14.06	8.18
Cash From Operations, 2 Yr. CAGR %	96.76	-	24.95	6.09	-6.54
Capital Expenditures, 2 Yr. CAGR %	40.7	-	-60.66	-13.32	-6.02
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	-	-25.77	4.04
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	-	-51.55	-13.88
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	21.26	-	11.4	10.26
Gross Profit, 3 Yr. CAGR %	-	21.26	-	11.4	10.26
EBITDA, 3 Yr. CAGR %	-	177.72	-	-9.19	-22.59
EBITA, 3 Yr. CAGR %	-	153.19	-	-10.17	-28.74
EBIT, 3 Yr. CAGR %	-	153.19	-	-14.22	-33.93
Earnings From Cont. Operations, 3 Yr. CAGR %	-	32.7	-	0.55	-36.67
Net Income, 3 Yr. CAGR %	-	32.67	-	5.16	-13.02
Normalized Net Income, 3 Yr. CAGR %	-	40.6	-	0.93	-6.24
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-59.77	-	-53.26	-15.45
Accounts Receivable, 3 Yr. CAGR %	-	17.97	-	51.9	45.47
Net Property, Plant and Equip., 3 Yr. CAGR %	-	9.07	-	-0.88	0.31
Total Assets, 3 Yr. CAGR %	-	21.54	-	6.3	6.3
Tangible Book Value, 3 Yr. CAGR %	-	108.81	-	11.65	10.26
Common Equity, 3 Yr. CAGR %	-	127.11	-	15.45	11.08
Cash From Operations, 3 Yr. CAGR %	-	63.15	-	8.08	6.74
Capital Expenditures, 3 Yr. CAGR %	-	11.43	-	-19.32	-41.95
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-	89.9
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-	31.44
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	17.02	-
Gross Profit, 5 Yr. CAGR %	-	-	-	17.02	-
EBITDA, 5 Yr. CAGR %	-	-	-	80.7	-
EBITA, 5 Yr. CAGR %	-	-	-	70.41	-
EBIT, 5 Yr. CAGR %	-	-	-	65.76	-
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	14.85	-
Net Income, 5 Yr. CAGR %	-	-	-	17.94	-
Normalized Net Income, 5 Yr. CAGR %	-	-	-	13.27	-
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-42.91	-
Accounts Receivable, 5 Yr. CAGR %	-	-	-	42.47	-
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	5.83	-
Total Assets, 5 Yr. CAGR %	-	-	-	16.86	-
Tangible Book Value, 5 Yr. CAGR %	-	-	-	62.84	-
Common Equity, 5 Yr. CAGR %	-	-	-	72.42	-
Cash From Operations, 5 Yr. CAGR %	-	-	-	37.35	-
Capital Expenditures, 5 Yr. CAGR %	-	-	-	0.78	-